Recent policies reflect China’s goal of promoting patients’ accessto innovative drugs. Noteworthy policy items include:

  • NHSA released Work Plan for the 2019 Adjustment to the National Reimbursement Drug List for public comment
  • NHSA released Opinions on the Implementation of National Centralized Procurement and Supporting Medical Insurance Measures
  • NHC Published Measures for the Management of Clinical Uses of Medical Devices for Public Comments
  • NHC released Implementation Plan for the Establishment of National Medical Hubs and Regional Medical Hubs

The latest issue could be downloaded Here

Leave a comment